Related Experiment Video
Updated: Jun 26, 2026

Using Unidirectional Rotations to Improve Vestibular System Asymmetry in Patients with Vestibular Dysfunction
Published on: August 30, 2019
Vestibular system in infants after systemic therapy with amikacin
1Diagnostic and Therapeutic Medical Centre Medicina, Kraków, Poland. olafzag@poczta.onet.pl
Insights
Aminoglycoside antibiotics can damage infant vestibular function. Caloric tests and vestibular evoked myogenic potentials (VEMPs) revealed more frequent vestibular than cochlear damage, highlighting the need for routine vestibular screening in infants post-treatment.
Area of Science:
- Pediatric Otolaryngology
- Neuroscience
- Pharmacology
Background:
- Aminoglycosides are crucial for treating infant infections but carry ototoxic risks.
- Routine infant inner ear examinations often omit vestibular function tests.
- Vestibular damage can have significant long-term impacts on development.
Purpose of the Study:
- To evaluate vestibular function in infants before and after aminoglycoside therapy.
- To compare the sensitivity of caloric tests and VEMPs in detecting aminoglycoside-induced ototoxicity.
- To determine if vestibular or cochlear function is more affected by amikacin treatment.
Main Methods:
- A randomized clinical study involving 68 infants (2.5-3.5 months old) at a tertiary referral center.
- Vestibular evoked myogenic potentials (VEMPs) and caloric stimulation were performed on 28 infants treated with amikacin and 40 healthy controls.
- Tests were conducted upon hospital admission and discharge to assess changes in vestibular function.
Main Results:
- No caloric stimulation response in 6 infants and no VEMPs in 4 infants upon discharge.
- Hearing thresholds remained normal in all infants throughout the study.
- Caloric testing proved more sensitive than VEMPs in detecting amikacin's ototoxic effects on vestibular receptors.
Conclusions:
- Amikacin treatment can damage both semicircular canal and otolith organ receptors in infants.
- The semicircular canal receptors appear to be more frequently impaired.
- Routine vestibular testing is recommended for infants following aminoglycoside therapy to monitor for ototoxicity.
Objective:
The ototoxic action of systemic therapy with aminoglycosides, used in vital infections in infants, is well recognized. Nevertheless, the routine examination of the infants' inner ear does not include vestibular tests. The purpose of the study was to evaluate vestibular function in a group of infants before and after administration of aminoglycosides, using caloric tests and vestibular evoked myogenic potentials (VEMPs).
Design:
Randomized clinical study.
Setting:
Tertiary referral centre.
Methods:
VEMPs and auditory brainstem responses were recorded and caloric stimulation was performed in 68 infants aged 2.5 to 3.5 months: 40 healthy controls and 28 infants after therapy with amikacin. Antibiotic therapy was administered for a respiratory infection in 18 infants and for sepsis in 10 infants. The tests were performed on the day of admission to hospital and on the day of discharge.
Main Outcome Measure:
The vestibular organ in infants after systemic therapy with amikacin was damaged more frequently than the cochlea.
Results:
On the day of discharge, no reaction to caloric stimulation was elicited in six patients and no VEMPs were recorded in four subjects. Hearing thresholds were normal in all of the individuals during both examinations. The caloric test was a more sensitive indication of the ototoxic impact of amikacin on the vestibular receptors, followed by VEMPs.
Conclusions:
Simultaneous impact of amikacin on the receptor cells of the vestibular organ causes damage to both the semicircular canal and otolith organ receptors. The function of the former is more frequently impaired. The vestibular tests should be performed in infants after treatment with aminoglycosides.
Related Concept Videos
The Vestibular System
Equilibrium and Balance
Estimation of k and VD of Aminoglycosides
Cryptococcal Meningitis
Drug Dosing: Infants and Children

